Invex Therapeutics Ltd IXC.AX
AUD0.11
Last Updated: Oct 06, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Invex Therapeutics Ltd Stock Halal?
Shariah Compliance Analysis of IXC.AX Stock
Australia Health Care Nano Cap No. As of October 2026, Invex Therapeutics Ltd (IXC.AX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Invex Therapeutics Ltd does not pass Musaffa's business and financial screening criteria.
Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-07-05. The firm is focused on the repurposing of an already-approved drug, Exenatide, for the efficacious treatment of neurological conditions derived from or involving raised intracranial pressure (ICP). In addition, the Company has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. The principal activity of the Company is the development of Exenatide, including generating new pre-clinical data in Alzheimer’s Disease (AD) under a collaboration with Tessara Therapeutics. The firm has trademarked its repurposed Exenatide as Presendin. The firm is focused on managing the close out of the Phase III Idiopathic Intracranial Hypertension (IIH) EVOLVE clinical trial and explore new potential applications for Exenatide in TBI and other neurological disorders with raised ICP, consistent with its patents.
IXC.AX Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Invex Therapeutics Ltd is classified as not halal.
NOT HALALInvex Therapeutics Ltd (IXC.AX) Chart
Fetching Price Chart...
Financial Metrics & Statements of Invex Therapeutics Ltd (IXC.AX)
FAQ's for Invex Therapeutics Ltd (IXC.AX)
- As of October 2026, Invex Therapeutics Ltd IXC.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Invex Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Invex Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Invex Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Invex Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Invex Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Invex Therapeutics Ltd (IXC.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
